Defects of T-cell effector function and post-thymic maturation in X-linked hyper-IgM syndrome

被引:82
作者
Jain, A
Atkinson, TP
Lipsky, PE
Slater, JE
Nelson, DL
Strober, W
机构
[1] NIAID, Mucosal Immun Sect, Clin Invest Lab, NIH, Bethesda, MD 20892 USA
[2] Univ Alabama, Dept Pediat, Birmingham, AL 35294 USA
[3] Univ Texas, SW Med Ctr, Dept Rheumatol & Immunol, Dallas, TX 75235 USA
[4] Childrens Natl Med Ctr, Dept Pediat, Washington, DC 20010 USA
[5] NCI, Immunophysiol Sect, Metab Branch, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1172/JCI5891
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
X-linked hyper-IgM syndrome (XHIM) results from mutations in the gene encoding for CD40 ligand (CD154). Patients with the syndrome suffer from infections with opportunistic pathogens such as Cryptosporidium and Pneumocystis carinii. In this study, we demonstrate that activated T cells from patients with XHIM produce markedly reduced levels of IFN-l, fail to induce antigen-presenting cells to synthesize IL-12, and induce greatly reduced levels of TNF-alpha. In addition, we show that the patients' circulating T lymphocytes of both the CD4(+) and CD8(+) subsets contain a markedly reduced antigen-primed population, as determined by CD45RO expression. Finally, we demonstrate that the defects in antigen priming are likely due to the lack of CD154 expression and insufficient costimulation of T cells by CD80/CD86 interactions. Taken together, this study offers a basis for the increased susceptibility of patients with XHIM to certain opportunistic infections.
引用
收藏
页码:1151 / 1158
页数:8
相关论文
共 47 条
[1]   Absence of IgD-CD27+ memory B cell population in X-linked hyper-IgM syndrome [J].
Agematsu, K ;
Nagumo, H ;
Shinozaki, K ;
Hokibara, S ;
Yasui, K ;
Terada, K ;
Kawamura, N ;
Toba, T ;
Nonoyama, S ;
Ochs, HD ;
Komiyama, A .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (04) :853-860
[2]   CD40 LIGAND GENE DEFECTS RESPONSIBLE FOR X-LINKED HYPER-IGM SYNDROME [J].
ALLEN, RC ;
ARMITAGE, RJ ;
CONLEY, ME ;
ROSENBLATT, H ;
JENKINS, NA ;
COPELAND, NG ;
BEDELL, MA ;
EDELHOFF, S ;
DISTECHE, CM ;
SIMONEAUX, DK ;
FANSLOW, WC ;
BELMONT, J ;
SPRIGGS, MK .
SCIENCE, 1993, 259 (5097) :990-993
[3]   Defective antigen-induced lymphocyte proliferation in the X-linked hyper-IgM syndrome [J].
Ameratunga, R ;
Lederman, HM ;
Sullivan, KE ;
Ochs, HD ;
Seyama, K ;
French, JK ;
Prestidge, R ;
Marbrook, J ;
Fanslow, WC ;
Winkelstein, JA .
JOURNAL OF PEDIATRICS, 1997, 131 (01) :147-150
[4]   THE CD40 LIGAND, GP39, IS DEFECTIVE IN ACTIVATED T-CELLS FROM PATIENTS WITH X-LINKED HYPER-IGM SYNDROME [J].
ARUFFO, A ;
FARRINGTON, M ;
HOLLENBAUGH, D ;
LI, X ;
MILATOVICH, A ;
NONOYAMA, S ;
BAJORATH, J ;
GROSMAIRE, LS ;
STENKAMP, R ;
NEUBAUER, M ;
ROBERTS, RL ;
NOELLE, RJ ;
LEDBETTER, JA ;
FRANCKE, U ;
OCHS, HD .
CELL, 1993, 72 (02) :291-300
[5]   Leukocyte transfusion-associated granulocyte responses in a patient with X-linked hyper-IgM syndrome [J].
Atkinson, TP ;
Smith, CA ;
Hsu, YM ;
Garber, E ;
Su, LH ;
Howard, TH ;
Prchal, JT ;
Everson, MP ;
Cooper, MD .
JOURNAL OF CLINICAL IMMUNOLOGY, 1998, 18 (06) :430-439
[6]   Help for cytotoxic-T-cell responses is mediated by CD40 signalling [J].
Bennett, SRM ;
Carbone, FR ;
Karamalis, F ;
Flavell, RA ;
Miller, JFAP ;
Heath, WR .
NATURE, 1998, 393 (6684) :478-480
[7]   CD40 LIGAND AND ITS ROLE IN X-LINKED HYPER-IGM SYNDROME [J].
CALLARD, RE ;
ARMITAGE, RJ ;
FANSLOW, WC ;
SPRIGGS, MK .
IMMUNOLOGY TODAY, 1993, 14 (11) :559-564
[8]   CD40 ligand is required for protective cell-mediated immunity to Leishmania major [J].
Campbell, KA ;
Ovendale, PJ ;
Kennedy, MK ;
Fanslow, WC ;
Reed, SG ;
Maliszewski, CR .
IMMUNITY, 1996, 4 (03) :283-289
[9]   ACTIVATION OF HUMAN DENDRITIC CELLS THROUGH CD40 CROSS-LINKING [J].
CAUX, C ;
MASSACRIER, C ;
VANBERVLIET, B ;
DUBOIS, B ;
VANKOOTEN, C ;
DURAND, I ;
BANCHEREAU, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (04) :1263-1272
[10]   Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation [J].
Cella, M ;
Scheidegger, D ;
PalmerLehmann, K ;
Lane, P ;
Lanzavecchia, A ;
Alber, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (02) :747-752